BridgeBio gets Brazil approval for ATTR-CM heart drug acoramidis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to BridgeBio gets Brazil approval for ATTR-CM heart drug acoramidis
(NASDAQ: BBIO) Delayed: 66.80 -0.75 (1.11%)
Previous Close $67.55    52 Week High $ 
Open $67.67    52 Week Low $ 
Day High $68.20    P/E N/A 
Day Low $66.79    EPS $ 
Volume 1,545,540